Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) and Harbour BioMed (HKEX: 02142) today announced that the National Medical Products Administration (NMPA) ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 9, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that ...
The Andrew Hillman Grant for Biotech announces its inaugural scholarship, designed to support undergraduate students pursuing careers in biotechnology ...
YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...
Fabulose is an EU funded project coordinated by the German Institutes of Textile and Fiber Research (DITF). Its consortium consists of leading research ...
Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 10:30 AM ESTCompany ParticipantsSujal Patel - Co-Founder, ...
24/7 Market News encourages readers and industry observers to obtain a copy of this month’s National Geographic to review the full feature and explore the scientific context in depth. Interested ...
Nautilus Biotechnology (NASDAQ:NAUT) used its fourth-quarter 2025 earnings call to highlight recent steps toward commercialization of its proteomics platform, alongside continued cost reductions and ...
Newsable Asianet News on MSN
Bharathiar University gets Rs 99.15 lakh DRDO project for antidotes
Bharathiar University has been sanctioned a Rs 99.15 lakh DRDO project to develop novel antidotes for toxic organophosphorous compounds. The 3-year project, under the DIA-CoE, will be led by Prof. N ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results